Zymergi LogoCart

483 Document: Intarcia Therapeutics, Inc., Jan 17, 2020

FDANews 483 Intarcia Therapeutics, Inc. Jan 17 2020 top
Jeffrey P. Raimondi FDA Investigator Uttaniti Limchumroon FDA Investigator Kouros Kangarli FDA Investigator Chiaochun J. Wang FDA Investigator

On Jan 17, 2020, the FDA inspected Intarcia Therapeutics, Inc.'s Hayward site. Explore the inspectional observations.